Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
39.71 USD | -0.72% | +3.28% | -13.62% |
Financials (USD)
Sales 2024 * | 132M | Sales 2025 * | 210M | Capitalization | 2.42B |
---|---|---|---|---|---|
Net income 2024 * | -280M | Net income 2025 * | -133M | EV / Sales 2024 * | 15.2 x |
Net cash position 2024 * | 416M | Net cash position 2025 * | 288M | EV / Sales 2025 * | 10.2 x |
P/E ratio 2024 * |
-9.53
x | P/E ratio 2025 * |
-19.8
x | Employees | 226 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.03% |
Latest transcript on Rhythm Pharmaceuticals, Inc.
1 day | -0.73% | ||
1 week | +3.28% | ||
Current month | -8.35% | ||
1 month | -2.07% | ||
3 months | -14.53% | ||
6 months | +77.28% | ||
Current year | -13.62% |
Managers | Title | Age | Since |
---|---|---|---|
David Meeker
CEO | Chief Executive Officer | 69 | 15-10-31 |
Hunter Smith
DFI | Director of Finance/CFO | 56 | 17-06-30 |
Joseph Shulman
CTO | Chief Tech/Sci/R&D Officer | 49 | 20-07-26 |
Members of the board | Title | Age | Since |
---|---|---|---|
Christophe Jean
BRD | Director/Board Member | 67 | 15-03-31 |
Jennifer Good
BRD | Director/Board Member | 59 | 19-06-18 |
David McGirr
BRD | Director/Board Member | 69 | 15-10-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.14% | 0 M€ | 0.00% | - | |
0.11% | 0 M€ | 0.00% | - | |
0.09% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 39.71 | -0.72% | 398,307 |
24-04-23 | 40 | +2.54% | 413,704 |
24-04-22 | 39.01 | +2.63% | 390,372 |
24-04-19 | 38.01 | -0.26% | 615,979 |
24-04-18 | 38.11 | -0.88% | 439,034 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.62% | 2.44B | |
-1.51% | 105B | |
+3.22% | 97.5B | |
+1.86% | 22.19B | |
-16.53% | 21.33B | |
-8.49% | 18.68B | |
-42.33% | 16.6B | |
-20.09% | 14.52B | |
+5.47% | 14.09B | |
+28.85% | 10.99B |
- Stock Market
- Equities
- RYTM Stock